Saudi Arabia Medical Imaging Market: Digital Imaging Growth, Precision Diagnosis & Hospital Expansion

Saudi Arabia’s medical imaging market is expanding rapidly as chronic disease prevalence, hospital capacity growth and digital transformation converge. IMARC Group valued the market at USD 443.7 million in 2025 and projects growth to USD 736.7 million by 2034, a compound annual growth rate of 5.80% from 2026–2034. Clinical demand from cardiovascular disease, diabetes and cancer—together with Vision 2030’s health priorities—has driven high equipment investment: cardiovascular disease affects 1.6% of Saudis aged 15 and above, rising to 11% among those aged 65 and over, with the Makkah region recording a 1.9% regional rate. Hospital expansion examples include an October 2024 collaboration between Hayat National Hospitals and GE Healthcare to deploy advanced diagnostic imaging across three new hospitals in Muhayl Aseer, Baysh and Buraida as Hayat moves to scale bed capacity to 3,000.

"Artificial intelligence is quickly moving from an experimental technology to an operational standard across Saudi Arabia's medical imaging landscape," Kishan Kumar writes in the report summary, reflecting a string of partnerships and product launches that are operationalizing AI in radiology workflows.

Industry activity confirms that transition. In November 2024 Recursive Inc. and the King Abdullah International Medical Research Center (KAIMRC) signed a memorandum of understanding at the Riyadh Global Medical Biotechnology Summit to develop an AI-based early screening system for tuberculosis, aligning with Vision 2030’s digital health agenda. Tele-radiology and AI-enabled interpretation are expanding access beyond major urban centres: PaxeraHealth and Saudi German Health extended their partnership in December 2024 to launch an AI-powered tele-radiology project covering 22 facilities across the MENA region, integrating real-time decision support to accelerate diagnostic turnaround.

Hospitals are also adopting higher-end modalities. The market is moving toward 3T MRI, PET-CT and hybrid imaging systems that provide combined anatomical and functional information for oncology, cardiology and neurology. Recent deployments and platform launches underline this shift: in April 2026 Johns Hopkins Aramco Healthcare rolled out the Agfa Enterprise Imaging platform to unify radiology and dental scans; King Faisal Specialist Hospital reported advancing more than 20 AI tools in March 2026 to improve diagnostic accuracy; and RapidAI partnered with Health Holdings Company in January 2026 to deploy deep clinical AI across 20 hospital clusters for stroke and aneurysm detection.

Recent developments

• April 2026 – Johns Hopkins Aramco Healthcare launches Agfa Enterprise Imaging platform, unifying radiology and dental scans.
• March 2026 – King Faisal Specialist Hospital advances over 20 AI tools to enhance diagnostic accuracy.
• February 2026 – PaxeraHealth extends AI teleradiology with Saudi German Health to 22 sites, delivering real-time imaging analysis.
• January 2026 – RapidAI partners with Health Holdings Company to deploy deep clinical AI across 20 hospital clusters.
• December 2025 – Saudi hospitals integrate advanced AI algorithms in radiology, reducing image interpretation times by 40% and improving oncology and cardiology precision.

Outlook for the sector is driven by sustained clinical demand and policy support tied to Vision 2030, including ambitions to grow medical tourism as part of a broader target of 150 million tourists by 2030 and a healthcare cooperation MoU with Thailand. With public-private partnerships, targeted hospital expansion and continued AI integration in imaging workflows, the market looks set to absorb investments in hybrid modalities, tele-radiology platforms and AI screening solutions as it moves toward the IMARC Group projection of USD 736.7 million by 2034.